These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10331827)

  • 1. Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model.
    White CM; Xie J; Chow MS; Kluger J
    Pharmacotherapy; 1999 May; 19(5):635-40. PubMed ID: 10331827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
    Carlsson L; Abrahamsson C; Drews L; Duker G
    Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.
    Carlsson L; Almgren O; Duker G
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):276-85. PubMed ID: 1697384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.
    Buchanan LV; Kabell G; Brunden MN; Gibson JK
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):540-9. PubMed ID: 7505355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs.
    Johna R; Mertens H; Haverkamp W; Eckardt L; Niederbröker T; Borggrefe M; Breithardt G
    Basic Res Cardiol; 1998 Apr; 93(2):127-35. PubMed ID: 9601580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
    D'Alonzo AJ; Zhu JL; Darbenzio RB
    Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
    Lu HR; Remeysen P; De Clerck F
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
    Hallman K; Carlsson L
    Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    Wang WQ; Robertson C; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of sodium in contrast medium-induced polymorphic ventricular tachycardia: results in a rabbit model of lengthened QT interval.
    Idée JM; Bourgoin-Balut C; Lefevre T; Zamia P; Goulas V; Gaillard S; Mathias C; Bonnemain B
    Acad Radiol; 1998 Jun; 5(6):435-43. PubMed ID: 9615154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adenosine A1-receptor activation on torsade de pointes in rabbits.
    Tan HL; Hou CJ; Sung RJ
    Cardiovasc Drugs Ther; 1999 Sep; 13(5):441-7. PubMed ID: 10547225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in corrected QT intervals at minimal and maximal heart rate may identify patients at risk for torsades de pointes during treatment with antiarrhythmic drugs.
    Buckingham TA; Bhutto ZR; Telfer EA; Zbilut J
    J Cardiovasc Electrophysiol; 1994 May; 5(5):408-11. PubMed ID: 8055145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological and pathological responses of TU waves to class Ia antiarrhythmic drugs.
    Maruyama T; Ohe T; Kurita T; Aihara N; Shimizu W
    Eur Heart J; 1995 May; 16(5):667-73. PubMed ID: 7588899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes].
    Li Y; Sun K; An MY; Pan YY; Sun T; Yin YQ; Kang Y; Lou JS
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):106-110. PubMed ID: 29926671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.